SAR-100842|SAR100842

Cas No.:	1195941-38-8
Chemical Name:	2-{4-methoxy-3-2-(3-methylphenyl)ethoxybenzamido}-2,3-dihydro-1H-indene-2-carboxylic acid
Synonyms:	2-[4-methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indane-2-carboxylic acid;Edg-2 receptor inhibitor 1;2-(4-METHOXY-3-(3-METHYLPHENETHOXY)BENZAMIDO)-2,3-DIHYDRO-1H-INDENE-2-CARBOXYLIC ACID(WXG02335);2-{4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzamido}-2,3-dihydro-1H-indene-2-carboxylic acid;1H-Indene-2-carboxylic acid, 2,3-dihydro-2-[[4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzoyl]amino]-;Edg 2 receptor inhibitor 1,Edg2 receptor inhibitor 1;2-{4-methoxy-3-2-(3-methylphenyl)ethoxybenzamido}-2,3-dihydro-1H-indene-2-carboxylic acid;EN300-265974;CZN001;CHEMBL3621969;1195941-38-8;Fipaxalparant (USAN/INN);SAR100842;A-003423457;VXB94138;1H-Indene-2-carboxylic acid, 2,3-dihydro-2-((4-methoxy-3-(2-(3-methylphenyl)ethoxy)benzoyl)amino)-;D12642;2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indane-2-carboxylic acid;HY-100185;A003423457;FIPAXALPARANT [INN];SAR-100842;2,3-Dihydro-2-[[4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzoyl]amino]-1H-Indene-2-carboxylic Acid;Y76WZ464EY;UNII-Y76WZ464EY;DB-121933;CS-0018180;2-{4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzamido}-1,3-dihydroindene-2-carboxylic acid;TS-09028;Z2492413932;FIPAXALPARANT [USAN];SOJDTNUCCXWTMG-UHFFFAOYSA-N;CZN-001;AKOS030525390;2-[[4-methoxy-3-[2-(3-methylphenyl)ethoxy]benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid;2-(4-Methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid;SCHEMBL1560214;HZN-825;2-(4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino)-indan-2-carboxylic acid;GTPL11315;FIPAXALPARANT
SMILES:	C1C2=C(C=CC=C2)CC1(NC(=O)C1=CC=C(OC)C(OCCC2=CC=CC(C)=C2)=C1)C(O)=O
Formula:	C₂₇H₂₇NO₅
M.Wt:	445.506987810135
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

SAR-100842 (SAR100842) is a potent, selective, orally available antagonist of the Lysophosphatidic Acid 1 Receptor (LPA1 receptor) with IC50 of 31 nM in β-arrestin assays; demonstrates potential for the treatment of systemic sclerosis and related fibrotic diseases.

COA

MSDS

Cat. No.	Product name	Field of application
DC10925	SAR-100842	SAR-100842 (SAR100842) is a potent, selective, orally available antagonist of the Lysophosphatidic Acid 1 Receptor (LPA1 receptor) with IC50 of 31 nM in β-arrestin assays.